Larvol Delta - Belantamab-Mafodotin-Plus-Vd-in-RelapsedRefractory-Multiple-Myeloma--an-Optimized-Regimen-Mitigates-Ocular-Adverse-Events-Without-Compromising-Clinical-Efficacy-A-Czech-Multicenter-Phase-2-Study

Blenrep (belantamab mafodotin-blmf) - GSK

https://imsannual2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=TU1XRFNPTlIyMjY0Nw&PosterID=826580&rnd=0.9385452

Tereza Popkova, MD

Sep 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next